Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.

Autor: Pivonello, R., Fleseriu, M., Newell-Price, J., Shimatsu, A., Feelders, R. A., Kadioglu, P., Tabarin, A., Brue, T. C., Geer, E. B., Piacentini, A., Pedroncelli, A. M., Biller, B. M. K.

Publikováno v: Journal of Endocrinological Investigation; Oct2024, Vol. 47 Issue 10, p2437-2448, 12p

Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Autor: van Haalen, F. M., Kaya, M., Pelsma, I. C.M., Dekkers, O. M., Biermasz, N. R., Cannegieter, S. C., Huisman, M. V., van Vlijmen, B. J.M., Feelders, R., Klok, F. A., Pereira, A. M., Stochholm, K., Fliers, E., Castinetti, F., Brue, T., Bertherat, J., Scaroni, C., Colao, A., Giordano, R., Druce, M. R., Beckers, A., Spranger, J., Driessens, N., Maiter, D., Feldt-Rasmussen, U., Webb, S. M., Dattani, M., Husebye, E., Zilaitiene, B., Gaztambide, S., Gatto, F., Ferone, D., Persani, L., Chiodini, I., Höybye, C., Meijer, O. C., Reincke, M., Vila, G., Perry, C., Heck, A., Stancampiano, M. R., van de Ven, A., Johannsson, G., Ragnarsson, O., Tóth, M.

Publikováno v: Orphanet Journal of Rare Diseases, 17, 1
Endo-ERN Cushing and Thrombosis study group 2022, ' Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) ', Orphanet Journal of Rare Diseases, vol. 17, no. 1, 178 . https://doi.org/10.1186/s13023-022-02320-x
Endo-ERN Cushing and Thrombosis study group 2022, ' Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) ', Orphanet Journal of Rare Diseases, vol. 17, 178 . https://doi.org/10.1186/s13023-022-02320-x
Orphanet Journal of Rare Diseases, 17
van Haalen, F M, Kaya, M, Pelsma, I C M, Dekkers, O M, Biermasz, N R, Cannegieter, S C, Huisman, M V, van Vlijmen, B J M, Feelders, R, Klok, F A, Pereira, A M, Stochholm, K, Fliers, E, Castinetti, F, Brue, T, Bertherat, J, Scaroni, C, Colao, A, Giordano, R, Druce, M R, Beckers, A, Spranger, J, Driessens, N, Maiter, D, Feldt-Rasmussen, U, Feelders, R, Webb, S M, Dattani, M, Husebye, E, Zilaitiene, B, Gaztambide, S, Gatto, F, Ferone, D, Persani, L, Chiodini, I, Höybye, C, Pereira, A M, Biermasz, N R, Klok, F A, Meijer, O C, Reincke, M, Vila, G, Perry, C, Heck, A, Stancampiano, M R, van de Ven, A, Johannsson, G, Ragnarsson, O, Tóth, M & Endo-ERN Cushing and Thrombosis study group 2022, ' Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN) ', Orphanet Journal of Rare Diseases, vol. 17, no. 1, 178 . https://doi.org/10.1186/s13023-022-02320-x
Orphanet Journal of Rare Diseases, 17. BMC
Orphanet journal of rare diseases, 17(1):178. BMC
Orphanet journal of rare diseases, 17(1):178. BioMed Central
Orphanet journal of rare diseases, Vol. 17, no.1, p. 178 [1-12] (2022)
Orphanet Journal of Rare Diseases, 17(1):178. BioMed Central
Orphanet Journal of Rare Diseases, 17(1):178. BioMed Central Ltd.

Background Cushing’s syndrome (CS) is associated with an hypercoagulable state and an increased risk of venous thromboembolism (VTE). Evidence-based guidelines on thromboprophylaxis strategies in patients with CS are currently lacking. We aimed to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa3db872260fe058a14d59181ff089d
http://www.scopus.com/inward/record.url?scp=85129997291&partnerID=8YFLogxK

High prevalence of venous thrombotic events in Cushing's syndrome: data from ERCUSYN and details in relation to surgery.

Autor: Isand K; Institute of Biomedicine and Translational Medicine, University of Tartu, Ülikooli 18, 50090, Tartu, Estonia., Feelders R; Department of Internal Medicine, Section of Endocrinology, ENETS Center of Excellence, Erasmus MC and Erasmus Cancer Institute, 3015 Rotterdam, The Netherlands., Brue T; Aix Marseille Univ, APHM, INSERM, MMG, Department of Endocrinology Hospital La Conception, MarMaRa Institute, 13305 Marseille, France., Toth M; Department of Internal Medicine and Oncology, Semmelweis University, 1083 Budapest, Hungary., Deutschbein T; Division of Endocrinology and Diabetes, Department of Internal Medicine I, University Hospital, University of Würzburg, 97080 Würzburg, Germany., Reincke M; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Ludwig-Maximilians-Universität München, 80336 Munich, Germany., Kršek M; Third Department of Internal Medicine, First Faculty of Medicine, Charles University, General University Hospital, 12808 Prague, Czech Republic., Santos A; IIB-Sant Pau and Department of Endocrinology, Hospital Sant Pau, Dept Medicine, UAB, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, 08025 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), Barcelona, Spain., Demtröder F; Zentrum für Endokrinologie, Diabetologie, Rheumatologie Dr. Demtröder & Kollegen, 44137 Dortmund, Germany., Chabre O; University Grenoble Alpes, UMR 1292 INSERM-CEA-UGA, Endocrinologie CHU Grenoble Alpes, F-38000 Grenoble, France., Strasburger CJ; Clinical Endocrinology, Charite-Universitätsmedizin, Campus Mitte, 10117 Berlin, Germany., Aulinas Maso A; IIB-Sant Pau and Department of Endocrinology, Hospital Sant Pau, Dept Medicine, UAB, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, 08025 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), Barcelona, Spain., Volke V; Institute of Biomedicine and Translational Medicine, University of Tartu, Ülikooli 18, 50090, Tartu, Estonia., Pereira AM; Department of Endocrinology & Metabolism, Amsterdam University Medical Center, and University of Amsterdam, 1081 Amsterdam, Netherlands., Lohmann R; Health Care Consulting GmbH, Lohmann & Birkner Health Care Consulting GmbH, 13407 Berlin, Germany., Gich Saladich I; Department of Clinical Epidemiology and Public Health, Hospital de la Santa Creu i Sant Pau (IIB Sant Pau), 08025 Barcelona, Spain., Webb SM; IIB-Sant Pau and Department of Endocrinology, Hospital Sant Pau, Dept Medicine, UAB, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBER-ER, Unidad 747), ISCIII, 08025 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), Barcelona, Spain., Wass J; Oxford Centre for Diabetes, Endocrinology and Metabolism, Oxford University Hospitals, OX37LE Oxford, United Kingdom., Valassi E; Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER, Unidad 747), Barcelona, Spain.; Endocrinology and Nutrition Department, Germans Trias i Pujol Hospital and Research Institute, Badalona 08916, Spain.

Publikováno v: European journal of endocrinology [Eur J Endocrinol] 2024 Jan 03; Vol. 190 (1), pp. 75-85.

Additional file 5 of Current clinical practice for thromboprophylaxis management in patients with Cushing’s syndrome across reference centers of the European Reference Network on Rare Endocrine Conditions (Endo-ERN)

Autor: van Haalen, F. M., Kaya, M., Pelsma, I. C. M., Dekkers, O. M., Biermasz, N. R., Cannegieter, S. C., Huisman, M. V., van Vlijmen, B. J. M., Feelders, R. A., Klok, F. A., Pereira, A. M.

Additional file 5: Secondary survey.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a181e368c03201f2441719b2f8d644f6